News Release 

COVID-19 news from Annals of Internal Medicine

All coronavirus-related content published in Annals is free

American College of Physicians

###

Below please find a summary and link(s) of new coronavirus-related content published today in Annals of Internal Medicine. The summary below is not intended to substitute for the full article as a source of information. A collection of coronavirus-related content is free to the public at http://go.annals.org/coronavirus.

1. Risks and Impact of ACEIs or ARBs in Adults With SARS-CoV-2 Infection

This living systematic review by researchers from Oregon Health & Science University and VA Portland Health Care System in Portland, Oregon, summarizes current evidence regarding whether the use of angiotensinconverting enzyme inhibitors or angiotensin-receptor blockers increases risk for SARS-CoV-2 infection or is associated with worse COVID-19 disease outcomes. Read the full text: https://www.acpjournals.org/doi/10.7326/M20-1515.

An accompanying editorial by William G. Kussmaul III, MD discusses the findings and emphasizes that, unless further data show otherwise, clinicians should continue to prescribe these drugs for their standard indications in patients with COVID-19. Read the full text: https://www.acpjournals.org/doi/10.7326/M20-3047.

Media contacts: A PDF for this article is not yet available. Please click the link to read full text. The lead author of the systematic review, Devan Kansagara, MD, MCR, can be reached through Erik Robinson at robineri@ohsu.edu or directly at kansagar@ohsu.edu. The lead author of the accompanying editorial, William G. Kussmaul III, MD, can be reached at w.kussmaul@verizon.net.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.